http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#Head
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#assertion
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#provenance
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#pubinfo
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#assertion
http://purl.obolibrary.org/obo/DOID_9538
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9538
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00188
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
http://www.w3.org/2000/01/rdf-schema#label
bortezomib for injection is a proteasome inhibitor indicated for treatment of patients with multiple myeloma 1 1 treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy 1 2 bortezomib for injection is indicated for the treatment of patients with multiple myeloma bortezomib for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00188
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#provenance
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#pubinfo
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig
http://purl.org/nanopub/x/hasSignature
dtVLUtonn7+7acexedTXXSLtoYsUK9Jz/sFet/bztf+9YYOX63NGGYnwPr+Db/0pfoZh2UReGCDeUsXtjbZRbSgM29R7slawzbKMspCnYmw+mcRArPgD9Aaa2mgxGbS+RUBXx/Mn2cb4ZfReo9Z2DkGGjVlQiF3q/RFgpyDoFc4=
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
http://purl.org/dc/terms/created
2021-06-27T20:11:57.454+02:00
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs